EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen

Gerrit Machetanz, Marc Grziwotz, Luisa Semmler, Mathias Maier, Christian Maegerlein, Marcus Deschauer

Journal of Neuromuscular Diseases · 2023

DOI: 10.3233/jnd-230032 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Neuromuscular Diseases, 2023. Verfasst von Gerrit Machetanz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. Hauptthemen laut MEDLINE: Arachnoid Cysts, Muscular Atrophy, Spinal, Intracranial Hypertension. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with spinal muscular atrophy (SMA) headache after intrathecal administration of nusinersen is usually attributed to post-lumbar puncture syndrome. However, lumbar puncture opening pressure (LOP) has also been reported to be increased in children with SMA, both before and after treatment with nusinersen, although symptoms associated with increased LOP were not observed. We report to our knowledge the first case of symptomatic intracranial hypertension in an adult SMA patient. This 21-year-old man suffered from headache and vomiting followed by visual disturbances after the 12th injection of nusinersen. Bilateral papilledema was recognized ophthalmologically. MRI of the head showed signs of intracranial hypertension and additionally arachnoid cysts but not hydrocephalus. Symptoms resolved after 8 weeks of treatment with repeated lumbar punctures and acetazolamide. This case raises the possibility of intracranial hypertension as a complication of nusinersen therapy although arachnoid cysts represent another risk factor for intracranial hypertension. We recommend that patients suffering from headache after nusinersen injections should not only be questioned and examined for symptoms suggestive of post-lumbar puncture syndrome, but also intracranial hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachnoid CystsMuscular Atrophy, SpinalIntracranial HypertensionMaleChildHumansAdultYoung AdultInjections, SpinalHeadacheSyndromeOligonucleotides

Stichwörter der Autor:innen

Spinal muscular atrophyantisense oligonucleotidesarachnoid cystsintracranial hypertensionnusinersen

Substanzen

nusinersenOligonucleotides

Autor:innen und Institutionen

  • Department of Neurology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Department of Ophthalmology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Zitieren

APA

Machetanz, G., Grziwotz, M., Semmler, L., Maier, M., Maegerlein, C., & Deschauer, M. (2023). Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-230032

Vancouver

Machetanz G, Grziwotz M, Semmler L, Maier M, Maegerlein C, Deschauer M. Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen. Journal of Neuromuscular Diseases. 2023. doi:10.3233/jnd-230032

BibTeX
@article{Machetanz2023,
  author = {Machetanz, Gerrit and Grziwotz, Marc and Semmler, Luisa and Maier, Mathias and Maegerlein, Christian and Deschauer, Marcus},
  title = {Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen},
  journal = {Journal of Neuromuscular Diseases},
  year = {2023},
  doi = {10.3233/jnd-230032}
}
Kostenlos starten →